ATC code relating to drugs affecting the blood and blood forming organs
Pharmaceutical drug classification
| ATC code B: Blood and blood forming organs |
|---|
|
| Other ATC codes |
ATC code B Blood and blood forming organs is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code B". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QB". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
|---|---|
| gastrointestinal tract / metabolism (A) | |
| blood and blood forming organs (B) | |
| cardiovascular system (C) | |
| skin (D) | |
| genitourinary system (G) | |
| endocrine system (H) | |
| infections and infestations (J, P, QI) | |
| malignant disease (L01–L02) | |
| immune disease (L03–L04) | |
| muscles, bones, and joints (M) | |
| brain and nervous system (N) |
|
| respiratory system (R) | |
| sensory organs (S) | |
| other ATC (V) | |
| Antiplatelet drugs |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticoagulants |
| ||||||||||||||
| Thrombolytic drugs/ fibrinolytics | |||||||||||||||
| Non-medicinal | |||||||||||||||
| |||||||||||||||
| Antihemorrhagics (coagulation) |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Antifibrinolytics | |||||||||||
| |||||||||||
| Erythropoietins | |
|---|---|
| Iron supplements | |
| Vitamin B12 and folic acid supplements | |
| HIF prolyl-hydroxylase inhibitors | |
| Other | |
Blood substitutes and perfusion solutions (B05) | |
|---|---|
| Blood and related products (B05A) | |
| Intravenous solutions (B05B) | |
| Irrigating solutions (B05C) | |
| Others (B05D, B05X) |
|
Other hematological agents (B06) | |
|---|---|
| Enzymes (B06AA) | |
| Drugs used in hereditary angioedema (B06AC) | |
| Drugs used in sickle cell disease and beta thalassemia (B06AX) | |
| Others | |
This pharmacology-related article is a stub. You can help Wikipedia by adding missing information. |